Lymphocytes and B-cell abnormalities in patients with common variable immunodeficiency (CVID)

Area of Science:

• Immunology
• Clinical Medicine

Background:

• Common variable immunodeficiency (CVID) is a primary antibody deficiency characterized by impaired antibody production.
• CVID presents with heterogeneous clinical and immunological features, including low or normal B-cell numbers.

Purpose of the Study:

• To investigate the clinical and immunological heterogeneity of CVID.
• To analyze B, T, and NK cell populations and key molecule expression in CVID patients.

Main Methods:

• Flow cytometry analysis of B, T, and NK cell populations.
• Assessment of CD27 expression for B-cell subset definition.
• Examination of molecules crucial for B-cell function, including TACI, ICOS, CD154, and CD40.

Main Results:

• Reduced B and T-cell numbers were observed in CVID patients, particularly in adults.
• Two patient groups were identified: one with significantly reduced CD27+ memory B-cells (group I) and another with normal levels (group II).
• All CVID patients showed lower expression of CD40 on B-cells and ICOS on T-cells compared to healthy donors, with a correlation between memory B-cells and clinical symptoms.

Conclusions:

• Combined T and B-cell defects may contribute to CVID pathogenesis in some individuals.
• Group I CVID patients with reduced memory B-cells experienced a higher frequency of pneumonia and chronic diarrhea.
• Immunological profiling reveals distinct CVID patient subgroups with potential implications for targeted therapies.